Guided Therapeutics, Inc. Awarded Third Year Funding of National Cancer Institute Grant for LuViva™ Advanced Cervical Scan
NORCROSS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCBB & OTCQB: GTHP), developer of a rapid and painless testing platform that uses biophotonics for the early detection of disease, today announced that it was awarded $517,000 to fund the third year of a $2.5 million three-year grant from the National Cancer Institute (NCI).